Patents Assigned to Idera Pharamaceuticals, Inc.
  • Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
    Patent number: 9243050
    Abstract: The invention relates to the therapeutic use of stabilized oligoribonucleotides as immune modulatory agents for immune therapy applications. Specifically, the invention provides RNA based oligoribonucleotides with improved nuclease and RNase stability and that have immune modulatory activity through TLR7 and/or TLR8.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: January 26, 2016
    Assignee: Idera Pharamaceuticals, Inc.
    Inventors: Ekambar R. Kandimalla, Tao Lan, Yukui Li, Dong Yu, Daqing Wang, Mallikarjuna Putta, Sudhir Agrawal